Category - Feature

Feature

iBio fast-tracking discovery for hard-to-drug targets with precision antibody therapeutics powered by AI and machine learning

iBio (NYSEA:IBO) is developing next-generation biopharmaceuticals leveraging computational biology and 3D-modeling of epitopes enabling the discovery of new antibody treatments for hard-to-target cancers and other...

February 6, 2024

Feature

TriSalus developing novel therapeutic solutions for liver and pancreatic tumors

TriSalus Life Sciences (NASDAQ:TLSI) is addressing the mechanical and biologic barriers within the tumor microenvironment (TME) that make it challenging to successfully treat liver and pancreatic tumors.

January 9, 2024

Feature

xNARA Biologics reinventing nutritional supplements through AI-based health risk scoring and microbiome testing

Closely-held xNARA Biologics is reshaping the wellness industry through personalized health and wellness solutions designed to address genetic predispositions and disorders identified by analyzing individual DNA, gut...

January 9, 2024

Feature

Simtra BioPharma Solutions leveraging more than 65 years of experience in bringing critical pharmaceutical products to market

Closely-held Simtra BioPharma Solutions, a premier contract development and manufacturing organization with more than 65 years of sterile injectable manufacturing experience, offers world-class cGMP sterile fill/finish...

December 19, 2023

Feature

Bridging clinical trial diversity gaps and accelerating R&D in rare disease

As founder and executive chair of the non-profit Indo-US Organization for Rare Disease (IndoUSrare), Harsha Rajasimha, Ph.D., social entrepreneur, and subject matter expert in bioinformatics, data analysis, and...

December 12, 2023

Feature

Personalis developing patient-specific test for earlier cancer detection

Personalis (NASDAQ:PSNL) is developing a liquid biopsy assay designed to detect minimal residual disease (MRD) and cancer recurrence earlier than other diagnostic methods.

December 5, 2023

Feature

Gritstone bio awaits preliminary Phase 2 data for personalized neoantigen vaccine

Gritstone bio (NASDAQ: GRTS) is expecting in the first quarter of 2024 preliminary data from its Phase 2/3 study evaluating the Company's personalized neoantigen vaccine candidate for the treatment of colorectal cancer...

November 28, 2023

Feature

Upswing Health harmonizes human touch with AI-driven technology to assess MSK pain

Closely-held Upswing Health, a virtual orthopedic company, is reinventing orthopedic care delivery through its virtual orthopedic musculoskeletal symptom assessment tool and customized pain management program...

November 21, 2023

Feature

Intrinsic Medicine developing new drugs for gut-immune-brain axis disorders

Closely-held Intrinsic medicine is developing new drugs for diseases that are linked to the disordered interaction of the gut microbiome, the immune system and the nervous system.

November 14, 2023

Feature

Rainhouse’s CNC machining expertise supporting specialty medical device manufacturing

Closely-held Rainhouse Manufacturing, a company specializing in computer numerical control (CNC) machining, quality assurance, and electronic manufacturing, is working with companies to make their medical device designs...

November 7, 2023

Category - Feature

iBio fast-tracking discovery for hard-to-drug targets with precision antibody therapeutics powered by AI and machine learning

TriSalus developing novel therapeutic solutions for liver and pancreatic tumors

xNARA Biologics reinventing nutritional supplements through AI-based health risk scoring and microbiome testing

Simtra BioPharma Solutions leveraging more than 65 years of experience in bringing critical pharmaceutical products to market

Bridging clinical trial diversity gaps and accelerating R&D in rare disease

Personalis developing patient-specific test for earlier cancer detection

Gritstone bio awaits preliminary Phase 2 data for personalized neoantigen vaccine

Upswing Health harmonizes human touch with AI-driven technology to assess MSK pain

Intrinsic Medicine developing new drugs for gut-immune-brain axis disorders

Rainhouse’s CNC machining expertise supporting specialty medical device manufacturing

General

More